DoW Melanoma Research Program Survivorship Research Award
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
DoW Melanoma Research Program Survivorship Research Award is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due October 14, 2026. Total estimated funding is $2.04M across about 2 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- May 21, 2026Posted
- Oct 14, 2026Application deadlinenext date
- Sep 30, 2027 (est.)Est. award date
- Nov 13, 2026Archived
- Posted
- May 21, 2026
- Close date
- Oct 14, 2026
- Archive date
- Nov 13, 2026
- Est. award date
- Sep 30, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $2,040,000
- Implied average award
- $1,020,000 calculated
- Expected awards
- 2
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
Distinctive Features:
· The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research.
· Clinical trials are allowed.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 12.420
Historical data · not a predictionWho was funded under ALN 12.420
Historical data · not a predictionSince October 1, 2023, 6,147 grant awards had funding actions under Military Medical Research and Development, with 2,218 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.$139M
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER$118M
- REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE$81.8M
- THE JOHNS HOPKINS UNIVERSITY$72.4M
- UNIVERSITY OF CALIFORNIA, LOS ANGELES$62.2M
Agency contact (as published)
Jamie Shortall Grant Officer
help@eBRAP.org
301-619-2393
Quick answers
When is the deadline for “DoW Melanoma Research Program Survivorship Research Award”?
According to the official notice, applications are due October 14, 2026. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for “DoW Melanoma Research Program Survivorship Research Award”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through “DoW Melanoma Research Program Survivorship Research Award”?
Per the notice, total estimated program funding is $2,040,000 and the agency expects to make about 2 awards.
How do I apply for “DoW Melanoma Research Program Survivorship Research Award”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526MRPSRA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DoW Melanoma Research Program Melanoma Academy Scholar Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Team Science Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Melanoma Research Program Idea Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 14, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Joint Warfighter Medical, Military Medical Research and Development Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Nov 16, 2026
- Who can apply
- Unrestricted (any entity type)
DoW Autism Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Oct 22, 2026
- Who can apply
- Unrestricted (any entity type)